These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1363188)

  • 1. Proteases and Protease Inhibitors in Alzheimer's Disease Pathogenesis. Proceedings of a conference. Bethesda, Maryland, December 16-18, 1991.
    Ann N Y Acad Sci; 1992 Dec; 674():1-259. PubMed ID: 1363188
    [No Abstract]   [Full Text] [Related]  

  • 2. The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease.
    Potter H; Nelson RB; Das S; Siman R; Kayyali US; Dressler D
    Ann N Y Acad Sci; 1992 Dec; 674():161-73. PubMed ID: 1288361
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteases and antiproteases. Proceedings of the 9th Transatlantic Airway Conference. Lucerne, Switzerland, January 1994.
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S107-89. PubMed ID: 7952643
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secretases as therapeutic targets for the treatment of Alzheimer's disease].
    Dejaegere T; de Strooper B
    Verh K Acad Geneeskd Belg; 2004; 66(1):29-58; discussion 58-9. PubMed ID: 15074081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic approaches in the therapy of Alzheimer's disease.
    Giacobini E
    Adv Exp Med Biol; 1990; 265():277-81. PubMed ID: 2198778
    [No Abstract]   [Full Text] [Related]  

  • 6. Proteases, protease inhibitors and protease-derived peptides. Importance in human pathophysiology and therapeutics. Symposium proceedings. Snowmass, Colorado, August 1992.
    Agents Actions Suppl; 1993; 42():1-248. PubMed ID: 8102833
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alzheimer's disease: focus on beta-amyloid and gamma-secretase].
    Iwatsubo T
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1086-90. PubMed ID: 15168534
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteases as prognostic markers in cancer.
    Verspaget HW
    BMJ; 1998 Mar; 316(7134):790-1. PubMed ID: 9549443
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent advances in Alzheimer's disease-related gamma-secretase complex].
    Tomita T; Iwatsubo T
    Seikagaku; 2004 Jul; 76(7):666-70. PubMed ID: 15346905
    [No Abstract]   [Full Text] [Related]  

  • 10. Old dogs and new tricks: proteases, inhibitors, and cell migration.
    Stefansson S; Lawrence DA
    Sci STKE; 2003 Jul; 2003(189):pe24. PubMed ID: 12837933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origins of a concept: the protease-antiprotease imbalance hypothesis.
    Turino GM
    Chest; 2002 Sep; 122(3):1058-60. PubMed ID: 12226052
    [No Abstract]   [Full Text] [Related]  

  • 12. [Unique structures of Alzheimer's gamma-secretase].
    Shirotani K
    Seikagaku; 2006 Jun; 78(6):537-40. PubMed ID: 16856568
    [No Abstract]   [Full Text] [Related]  

  • 13. The plant proteolytic machinery and its role in defence.
    van der Hoorn RA; Jones JD
    Curr Opin Plant Biol; 2004 Aug; 7(4):400-7. PubMed ID: 15231262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational approaches to the prediction of blood-brain barrier permeability: A comparative analysis of central nervous system drugs versus secretase inhibitors for Alzheimer's disease.
    Rishton GM; LaBonte K; Williams AJ; Kassam K; Kolovanov E
    Curr Opin Drug Discov Devel; 2006 May; 9(3):303-13. PubMed ID: 16729726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinase inhibitors - IBC's Third International Conference. New approaches, new discoveries, new targets.
    Durrance A
    IDrugs; 2004 Feb; 7(2):140-2. PubMed ID: 15057658
    [No Abstract]   [Full Text] [Related]  

  • 16. [Brain proteinase activity and the mobilization of endogenous proteolytic inhibitors as factors in the development of the functional state of the body].
    Gurin VN; Sandakov DB; Gurin AV
    Fiziol Cheloveka; 1999; 25(1):71-7. PubMed ID: 10204297
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proteinase/antiproteinase balance in patients with cystic fibrosis].
    Welte T
    Pneumologie; 1996 Dec; 50 Suppl 3():838-40. PubMed ID: 9157439
    [No Abstract]   [Full Text] [Related]  

  • 18. BACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's disease.
    Dominguez DI; Hartmann D; De Strooper B
    Neurodegener Dis; 2004; 1(4-5):168-74. PubMed ID: 16908986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: a compendium of current theories. Proceedings of a conference. April 30-May 2, 1999. Orlando, Florida, USA.
    Ann N Y Acad Sci; 2000; 924():1-195. PubMed ID: 11193784
    [No Abstract]   [Full Text] [Related]  

  • 20. The participation of interleukin-6 in the pathogenesis of Alzheimer's disease.
    Bauer J; Ganter U; Strauss S; Stadtmüller G; Frommberger U; Bauer H; Volk B; Berger M
    Res Immunol; 1992; 143(6):650-7. PubMed ID: 1280850
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.